Suppr超能文献

召回的起搏器和植入式心脏复律除颤器的管理:一种决策分析模型

Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model.

作者信息

Amin Mitesh S, Matchar David B, Wood Mark A, Ellenbogen Kenneth A

机构信息

Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, USA.

出版信息

JAMA. 2006 Jul 26;296(4):412-20. doi: 10.1001/jama.296.4.412.

Abstract

CONTEXT

Limited information exists to direct clinical management after an implantable device has been put under advisory. A better understanding of the risks and benefits of device replacement compared with continued clinical follow-up would be helpful to clinicians.

OBJECTIVE

Using the tools of decision analysis, to determine the best management approach (immediate device replacement vs continued monitoring) in the setting of a device advisory.

DESIGN

A decision model was constructed to evaluate the risks and benefits associated with immediate device replacement compared with continued monitoring.

MAIN OUTCOME MEASURES

Variables considered included indications for device implantation, anticipated course following device failure, device failure rates from the advisory ranging from 0.0001% to 1.0% per year, and device replacement mortality rates ranging from 0.10% to 1.00% per procedure. Device replacement was preferred to continued follow-up when replacement led to greater patient survival.

RESULTS

The decision to replace a recalled device depends primarily on the advisory's estimated device failure rate and the likely effects of device failure on mortality. Procedural mortality is an important secondary factor, while patient age and remaining generator life have the least influence on the decision. For pacemaker-dependent patients, advisory device failure rates exceeding 0.3% warrant device replacement in most situations. In patients with implantable cardioverter-defibrillators for primary or secondary prevention, a failure rate associated with an advisory of 3.0% is needed to favor replacement in most cases, decreasing to close to 1.0% as procedural mortality rates decrease to 0.1% or risk of fatal arrhythmias increase to near 20% per year. In cases of pacemaker implantation for non-life-threatening situations (eg, carotid sinus hypersensitivity), most device advisories do not warrant device replacement.

CONCLUSIONS

The decision to replace a device under advisory is determined primarily by the incidence of device malfunction and the likely effects of device failure. This analysis provides a framework for managing recalled devices in the context of device, patient, and institutional characteristics.

摘要

背景

关于植入式设备被发出咨询建议后如何指导临床管理的信息有限。更好地了解与设备更换相比继续进行临床随访的风险和益处,将有助于临床医生。

目的

使用决策分析工具,确定在设备咨询建议情况下的最佳管理方法(立即更换设备与继续监测)。

设计

构建一个决策模型,以评估与立即更换设备相比继续监测相关的风险和益处。

主要结局指标

考虑的变量包括设备植入的指征、设备故障后的预期病程、咨询建议中每年0.0001%至1.0%的设备故障率,以及每次手术0.10%至1.00%的设备更换死亡率。当更换能带来更高的患者生存率时,更换设备优于继续随访。

结果

决定更换召回设备主要取决于咨询建议中估计的设备故障率以及设备故障对死亡率的可能影响。手术死亡率是一个重要的次要因素,而患者年龄和剩余发生器寿命对该决定的影响最小。对于依赖起搏器的患者,在大多数情况下,咨询建议中的设备故障率超过0.3%就需要更换设备。对于用于一级或二级预防的植入式心律转复除颤器患者,在大多数情况下,咨询建议中的故障率达到3.0%时才倾向于更换,随着手术死亡率降至0.1%或致命性心律失常风险每年增至近20%,该故障率可降至接近1.0%。在因非危及生命情况(如颈动脉窦过敏)植入起搏器的病例中,大多数设备咨询建议并不需要更换设备。

结论

决定更换被发出咨询建议的设备主要由设备故障的发生率以及设备故障的可能影响来决定。该分析提供了一个在设备、患者和机构特征背景下管理召回设备的框架。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验